Additional in vivo evidence comes from various studies of prion and other neurodegenerative diseases that show an increase in ER quality control molecules, including ER chaperones and disulfide isomerases, in diseased brains (42, –, 46). This evidence concerns the gene TXNDC15 and neurodegenerative disease.